I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 21% ± 4% | |
| glutamatergic neuron | 3 studies | 21% ± 4% | |
| oligodendrocyte precursor cell | 3 studies | 21% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 21% ± 4% | |
| glutamatergic neuron | 3 studies | 21% ± 4% | |
| oligodendrocyte precursor cell | 3 studies | 21% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 18% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 377.97 | 2641 / 2642 | 100% | 6.61 | 702 / 705 |
| thymus | 100% | 297.28 | 653 / 653 | 93% | 3.60 | 560 / 605 |
| adrenal gland | 98% | 154.62 | 252 / 258 | 83% | 2.99 | 192 / 230 |
| prostate | 100% | 267.40 | 245 / 245 | 79% | 1.85 | 396 / 502 |
| breast | 100% | 289.40 | 459 / 459 | 74% | 1.96 | 829 / 1118 |
| kidney | 100% | 199.20 | 89 / 89 | 72% | 1.97 | 645 / 901 |
| uterus | 100% | 455.87 | 170 / 170 | 68% | 1.86 | 312 / 459 |
| pancreas | 94% | 122.55 | 307 / 328 | 72% | 1.45 | 128 / 178 |
| esophagus | 99% | 220.96 | 1427 / 1445 | 63% | 1.51 | 115 / 183 |
| ovary | 100% | 573.17 | 180 / 180 | 58% | 1.12 | 251 / 430 |
| lung | 91% | 151.12 | 528 / 578 | 61% | 1.34 | 705 / 1155 |
| skin | 95% | 187.01 | 1710 / 1809 | 53% | 1.27 | 250 / 472 |
| bladder | 100% | 286.14 | 21 / 21 | 46% | 0.92 | 230 / 504 |
| intestine | 96% | 216.03 | 932 / 966 | 34% | 0.66 | 181 / 527 |
| stomach | 90% | 148.36 | 324 / 359 | 34% | 0.63 | 96 / 286 |
| spleen | 100% | 203.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 246.99 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 249.01 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| heart | 95% | 128.69 | 818 / 861 | 0% | 0 | 0 / 0 |
| muscle | 93% | 128.96 | 745 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 1.96 | 33 / 45 |
| liver | 55% | 42.25 | 124 / 226 | 17% | 0.31 | 70 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 0.72 | 12 / 29 |
| peripheral blood | 18% | 27.56 | 167 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 13% | 0.20 | 10 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | ZFP37 |
| Protein name | Zinc finger protein 37 homolog (Zfp-37) |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000374227.8 [Q9Y6Q3-1] Q9Y6Q3 ENST00000553380.1 [Q9Y6Q3-2] ENST00000555206.5 [Q9Y6Q3-3] |
